Concepedia

Author

Jonathan A. Leff

University of Colorado Health

Also Known As

J A Leff, J LEFF, JONATHAN A. LEFF, Jonathan A Leff, Jonathan A. Leff, Jonathan Leff

61

Publications

3.2K

Citations

26

H-Index

59

Concepts

All Affiliations

University of Colorado HealthUniversity of Colorado DenverAscendis Pharma (Denmark)Merck & Co., Inc., Rahway, NJ, USA (United States)Amgen (United States)
JA

About

Jonathan A. Leff is an author at University of Colorado Health specializing in medicine, pharmacology, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

764

2

Allergy

3

3

241

3

Humanities

1

1

47

4

Language Studies

1

1

47

5

Natural Sciences

1

1

26

Jonathan A. Leff

×

30

Publications

2.5K

Citations

25

H-Index

YearCitations

Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction

Jonathan A. Leff, David S. Pearlman, Edwin A. Bronsky,

New England Journal of Medicine

1998

555

6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis

Roland M. du Bois, Carlo Albera, Williamson Z. Bradford,

European Respiratory Journal

2013

236

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction

César Villarán, Shane O’Neill, Arthur Helbling,

Journal of Allergy and Clinical Immunology

1999

181

All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials

Talmadge E. King, Carlo Albera, Williamson Z. Bradford,

American Journal of Respiratory and Critical Care Medicine

2014

155

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

Haiyung Cheng, Jonathan A. Leff, Raju D. Amin,

Pharmaceutical Research

1996

139

Disparate Antioxidant Enzyme Activities in Cultured Human Cutaneous Fibroblasts, Keratinocytes, and Melanocytes

Joseph Yohn, David A. Norris, David G Yrastorza,

Journal of Investigative Dermatology

1991

136

Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.

Mark C. Genovese, Joan M. Bathon, Roy Fleischmann,

PubMed

2005

123

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.

Boulos Haraoui, Edward Keystone, Carter Thorne,

PubMed

2004

102

Generation of superoxide anion by brain endothelial cell xanthine oxidase

Lance S. Terada, Irene R. Willingham, Mary E. Rosandich,

Journal of Cellular Physiology

1991

99

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

Arthur L. Weaver, Richard L. Lautzenheiser, Michael Schiff,

Current Medical Research and Opinion

2005

65

Page 1